Mobilisation of Hematopoietic CD34⁺ Precursor Cells in Patients with Acute Stroke Is Safe - Results of an Open-Labeled Non Randomized Phase I/II Trial

• Sandra Boy ,

  Contributed equally to this work with: Sandra Boy, Sophie Sauerbruch

  * E-mail: sandra.boy@medbo.de

  Affiliation Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany

  ⨯
• Sophie Sauerbruch ,

  Contributed equally to this work with: Sandra Boy, Sophie Sauerbruch

  Affiliation Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany

  ⨯
• Mathias Kraemer,

  Affiliation Neurological Therapy Center and St. Marien Hospital, Köln, Germany

  ⨯
• Thorsten Schormann,

  Affiliation Department of Neurology, University Medical Centre, Düsseldorf, Germany

  ⨯
• Felix Schlachetzki,

  Affiliation Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany

  ⨯
• Gerhard Schuierer,

  Affiliation Institute of Neuroradiology, Regensburg University Medical Centre, District Medical Centre Regensburg, Regensburg, Germany

  ⨯
• Ralph Luerding,

  Affiliation Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany

  ⨯
• Burkhard Hennemann,

  Affiliation Department of Hemato-Oncology, Regensburg University Medical Centre, Regensburg, Germany

  ⨯
• Evelyn Orso,

  Affiliation Department of Clinical Chemistry, Regensburg University Medical Centre, Regensburg, Germany

  ⨯
• Andreas Dabringhaus,

  Affiliation St. Mauritius Therapy Clinic, Meerbusch, Germany

  ⨯
• Jürgen Winkler,

  Affiliation Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany

  ⨯
• Ulrich Bogdahn,

  Affiliation Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany

  ⨯
• for the RAIS (Regeneration in Acute Ischemic Stroke) Study Group